203 related articles for article (PubMed ID: 22088206)
21. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
22. Early metabolic derangements in daughters of women with polycystic ovary syndrome.
Sir-Petermann T; Maliqueo M; Codner E; Echiburú B; Crisosto N; Pérez V; Pérez-Bravo F; Cassorla F
J Clin Endocrinol Metab; 2007 Dec; 92(12):4637-42. PubMed ID: 17848407
[TBL] [Abstract][Full Text] [Related]
23. Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome.
Ben Ayed B; Dammak dit Mlik S; Ben Arab H; Trabelssi H; Chahtour H; Mathlouthi N; Dhuib M; Kassis M; Saiidane D; Trabelssi K; Guermazi M
Tunis Med; 2009 Jan; 87(1):43-9. PubMed ID: 19522426
[TBL] [Abstract][Full Text] [Related]
24. Circulating Anti-Müllerian Hormone Levels in Daughters of Women with and without Polycystic Ovary Syndrome.
Olszanecka-Glinianowicz M; Zachurzok A; Drosdzol-Cop A; Bożętowicz-Wikarek M; Owczarek A; Gawlik A; Chudek J; Skrzypulec-Plinta V; Małecka-Tendera E
Horm Res Paediatr; 2016; 85(6):372-8. PubMed ID: 27173495
[TBL] [Abstract][Full Text] [Related]
25. [Indication of metformin in the management of hormonal dysfunction secondary to polycystic ovarian syndrome: prospective comparative study of 63 cases].
Boudhrâa K; Jellouli MA; Amri M; Farhat M; Torkhani F; Gara MF
Tunis Med; 2010 May; 88(5):335-40. PubMed ID: 20517830
[TBL] [Abstract][Full Text] [Related]
26. Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).
Vosnakis C; Georgopoulos NA; Rousso D; Mavromatidis G; Katsikis I; Roupas ND; Mamali I; Panidis D
Gynecol Endocrinol; 2013 Mar; 29(3):242-5. PubMed ID: 23194076
[TBL] [Abstract][Full Text] [Related]
27. Anti-Müllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome.
Carlsen SM; Vanky E; Fleming R
Hum Reprod; 2009 Jul; 24(7):1732-8. PubMed ID: 19342396
[TBL] [Abstract][Full Text] [Related]
28. [Anti-Mullerian hormone- its role in the pathogenesis of the polycystic ovary syndrome].
Parahuleva N; Pehlivanov B; Dimitrakova E; Malinova M; Mladenova M
Akush Ginekol (Sofiia); 2012; 51(6):22-6. PubMed ID: 23390860
[TBL] [Abstract][Full Text] [Related]
29. Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome.
Nawaz FH; Rizvi J
Gynecol Obstet Invest; 2010; 69(3):184-9. PubMed ID: 20029224
[TBL] [Abstract][Full Text] [Related]
30. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.
Vanky E; Salvesen KA; Heimstad R; Fougner KJ; Romundstad P; Carlsen SM
Hum Reprod; 2004 Aug; 19(8):1734-40. PubMed ID: 15178665
[TBL] [Abstract][Full Text] [Related]
31. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
Song J; Shen H; Li J; Huang Z; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071
[TBL] [Abstract][Full Text] [Related]
32. Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome.
Khorram O; Helliwell JP; Katz S; Bonpane CM; Jaramillo L
Fertil Steril; 2006 May; 85(5):1448-51. PubMed ID: 16579997
[TBL] [Abstract][Full Text] [Related]
33. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
34. [Role of hyperinsulinemia in pathogenesis of polycystic ovary syndrome and treatment by reduction of insulin secretion].
Wang A; Li M; Lu C
Zhonghua Fu Chan Ke Za Zhi; 1998 Dec; 33(12):731-4. PubMed ID: 10806662
[TBL] [Abstract][Full Text] [Related]
35. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
Dewailly D; Pigny P; Soudan B; Catteau-Jonard S; Decanter C; Poncelet E; Duhamel A
J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596
[TBL] [Abstract][Full Text] [Related]
36. Association of metformin and pregnancy in the polycystic ovary syndrome. A report of three cases.
Seale FG; Robinson RD; Neal GS
J Reprod Med; 2000 Jun; 45(6):507-10. PubMed ID: 10900588
[TBL] [Abstract][Full Text] [Related]
37. Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment.
Fleming R; Harborne L; MacLaughlin DT; Ling D; Norman J; Sattar N; Seifer DB
Fertil Steril; 2005 Jan; 83(1):130-6. PubMed ID: 15652898
[TBL] [Abstract][Full Text] [Related]
38. Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome.
Mashiach R; Amit A; Hasson J; Amzalzg S; Almog B; Ben-Yosef D; Lessing JB; Limor R; Azem F
Fertil Steril; 2010 May; 93(7):2299-302. PubMed ID: 19261276
[TBL] [Abstract][Full Text] [Related]
39. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
40. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.
Palomba S; Falbo A; Di Cello A; Cappiello F; Tolino A; Zullo F
Fertil Steril; 2011 Nov; 96(5):1128-33. PubMed ID: 21917254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]